Literature DB >> 6862799

Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs.

J T Ernest, T K Goldstick, R L Engerman.   

Abstract

Preretinal oxygen tensions were measured continuously using microelectrodes in four normal dogs and four dogs made diabetic with alloxan. The latter were kept under poor control for 8 months. Glucose administered intravenously in 30 to 90 sec to all the dogs when they were normoglycemic caused an immediate increase in preretinal oxygen tension lasting approximately 10 min. When the dogs were given 100% oxygen to breathe, their preretinal oxygen tensions increased. This increase in preretinal oxygen tension was 36.6 +/- 8.5 mmHg (+/-SE) when the animals were normoglycemic and 63.5 +/- 9.2 mmHg when the animals were made hyperglycemic. This suggests that hyperglycemia impairs oxygen autoregulation. Moreover, the diabetic dogs appeared to exhibit a larger preretinal oxygen tension increase than normal dogs when both were given 100% oxygen to breathe. The small number of animals studied, however, makes a comparison between the two groups difficult. These data lead one to speculate that in diabetes there may be an impairment of the normal retinal vascular homeostasis. This could play a role in both the development and in the severity of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6862799

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

1.  Plasma endothelin-1 levels depress optic nerve head circulation detected during the glucose tolerance test.

Authors:  Teruyo Kida; Tetsuya Sugiyama; Hidehiro Oku; Seiyo Harino; Tsunehiko Ikeda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-17       Impact factor: 3.117

2.  Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.

Authors:  J R Williamson; E Ostrow; D Eades; K Chang; W Allison; C Kilo; W R Sherman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  A laser Doppler velocimetry study of the effect of hypoglycaemia on retinal blood flow in the minipig.

Authors:  G Caldwell; E G Davies; P M Sullivan; A H Morris; E M Kohner
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

Review 4.  Ocular oxygen measurement.

Authors:  I M Hogeboom van Buggenum; G L van der Heijde; G J Tangelder; J W Reichert-Thoen
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

5.  Isovolemic hemodilution increases retinal tissue oxygen tension.

Authors:  K A Neely; J T Ernest; T K Goldstick; R A Linsenmeier; J Moss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-11       Impact factor: 3.117

6.  Effects of intensified insulin treatment on retinal vessels in diabetic patients.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; K F Hanssen; L Sandvik
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

7.  Strict control of glycaemia: effects on blood flow in the large retinal vessels and in the macular microcirculation.

Authors:  J E Grunwald; C E Riva; B L Petrig; A J Brucker; S S Schwartz; S N Braunstein; J DuPont; S Grunwald
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

8.  Foveolar choroidal hemodynamics in proliferative diabetic retinopathy.

Authors:  Lisa S Schocket; Allison J Brucker; Rachel M Niknam; Juan E Grunwald; Joan DuPont; Alexander J Brucker
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

9.  Diabetic patients with retinopathy show increased retinal venous oxygen saturation.

Authors:  Martin Hammer; Walthard Vilser; Thomas Riemer; Aleksandra Mandecka; Dietrich Schweitzer; Uta Kühn; Jens Dawczynski; Fanny Liemt; Jürgen Strobel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-29       Impact factor: 3.117

10.  Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes.

Authors:  G Garhöfer; C Zawinka; H Resch; P Kothy; L Schmetterer; G T Dorner
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.